Katie J Suda1,2, Lauri A Hicks3, Rebecca M Roberts3, Robert J Hunkler4, Linda M Matusiak4, Glen T Schumock2. 1. Center of Innovation for Complex Chronic Healthcare, Department of Veterans Affairs, Edward Hines Jr. Veterans Affairs Hospital, Illinois. 2. Department of Pharmacy Systems, Outcomes, and Policy, College of Pharmacy, University of Illinois at Chicago. 3. Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia. 4. Professional Relations, QuintilesIMS, Plymouth Meeting, Pennsylvania.
Abstract
Background: Improving antibiotic use has the potential to decrease healthcare costs by reducing the incidence of antibiotic-resistant infections, antibiotic-associated adverse events, and expenditures due to unnecessary prescriptions. Antibiotic expenditures in 2009 totaled $10.7 billion in the United States. Since then, national and local antibiotic stewardship initiatives have grown. The purpose of this study was to assess trends in antibiotic expenditures by healthcare setting in the United States between 2010 and 2015. Methods: Systemic (nontopical) antibiotic expenditures from January 2010 to December 2015 were extracted from the QuintilesIMS National Sales Perspectives database. These data represent a statistically valid projection of US medication purchases. Regression analyses evaluated trends in expenditures over the study period. Results: Antibiotic expenditures totaled $56.0 billion over the 6-year period; the majority (59.1%) of expenditures were associated with the outpatient setting. Overall antibiotic expenditures in 2015 ($8.8 billion) were 16.6% lower than in 2010 ($10.6 billion). Antibiotic expenditures similarly decreased in the community by 25.5% (P = .05), but outpatient clinics and mail service pharmacy expenditures experienced significant growth (148% and 67% increase, respectively; P < .01 for both). In 2015, 16.5% of antibiotic expenditures in the community were for parenteral formulations, an increase of 25%. Conclusions: From 2010 to 2015, antibiotic expenditures decreased. The majority of antibiotic expenditures were in the outpatient setting, specifically community pharmacies. Expenditures for intravenous agents in the community are increasing and may represent increased use. These results reinforce the importance of antibiotic stewardship efforts across the spectrum of healthcare. Published by Oxford University Press for the Infectious Diseases Society of America 2017. This work is written by (a) US Government employee(s) and is in the public domain in the US.
Background: Improving antibiotic use has the potential to decrease healthcare costs by reducing the incidence of antibiotic-resistant infections, antibiotic-associated adverse events, and expenditures due to unnecessary prescriptions. Antibiotic expenditures in 2009 totaled $10.7 billion in the United States. Since then, national and local antibiotic stewardship initiatives have grown. The purpose of this study was to assess trends in antibiotic expenditures by healthcare setting in the United States between 2010 and 2015. Methods: Systemic (nontopical) antibiotic expenditures from January 2010 to December 2015 were extracted from the QuintilesIMS National Sales Perspectives database. These data represent a statistically valid projection of US medication purchases. Regression analyses evaluated trends in expenditures over the study period. Results: Antibiotic expenditures totaled $56.0 billion over the 6-year period; the majority (59.1%) of expenditures were associated with the outpatient setting. Overall antibiotic expenditures in 2015 ($8.8 billion) were 16.6% lower than in 2010 ($10.6 billion). Antibiotic expenditures similarly decreased in the community by 25.5% (P = .05), but outpatient clinics and mail service pharmacy expenditures experienced significant growth (148% and 67% increase, respectively; P < .01 for both). In 2015, 16.5% of antibiotic expenditures in the community were for parenteral formulations, an increase of 25%. Conclusions: From 2010 to 2015, antibiotic expenditures decreased. The majority of antibiotic expenditures were in the outpatient setting, specifically community pharmacies. Expenditures for intravenous agents in the community are increasing and may represent increased use. These results reinforce the importance of antibiotic stewardship efforts across the spectrum of healthcare. Published by Oxford University Press for the Infectious Diseases Society of America 2017. This work is written by (a) US Government employee(s) and is in the public domain in the US.
Authors: Emily Sydnor Spivak; Brian Kendall; Patricia Orlando; Christian Perez; Marina De Amorim; Matthew Samore; Andrew T Pavia; Adam L Hersh Journal: Infect Control Hosp Epidemiol Date: 2015-05-26 Impact factor: 3.254
Authors: Fred Doloresco; Cory Fominaya; Glen T Schumock; Lee C Vermeulen; Linda Matusiak; Robert J Hunkler; Nilay D Shah; James M Hoffman Journal: Am J Health Syst Pharm Date: 2011-05-15 Impact factor: 2.637
Authors: Glen T Schumock; Edward C Li; Katie J Suda; Linda M Matusiak; Robert J Hunkler; Lee C Vermeulen; James M Hoffman Journal: Am J Health Syst Pharm Date: 2014-03-15 Impact factor: 2.637
Authors: Lauri A Hicks; Monina G Bartoces; Rebecca M Roberts; Katie J Suda; Robert J Hunkler; Thomas H Taylor; Stephanie J Schrag Journal: Clin Infect Dis Date: 2015-03-05 Impact factor: 9.079
Authors: Katherine E Fleming-Dutra; Adam L Hersh; Daniel J Shapiro; Monina Bartoces; Eva A Enns; Thomas M File; Jonathan A Finkelstein; Jeffrey S Gerber; David Y Hyun; Jeffrey A Linder; Ruth Lynfield; David J Margolis; Larissa S May; Daniel Merenstein; Joshua P Metlay; Jason G Newland; Jay F Piccirillo; Rebecca M Roberts; Guillermo V Sanchez; Katie J Suda; Ann Thomas; Teri Moser Woo; Rachel M Zetts; Lauri A Hicks Journal: JAMA Date: 2016-05-03 Impact factor: 56.272
Authors: Katie J Suda; Lauri A Hicks; Rebecca M Roberts; Robert J Hunkler; Thomas H Taylor Journal: Antimicrob Agents Chemother Date: 2014-03-03 Impact factor: 5.191
Authors: Peter Davey; Erwin Brown; Esmita Charani; Lynda Fenelon; Ian M Gould; Alison Holmes; Craig R Ramsay; Philip J Wiffen; Mark Wilcox Journal: Cochrane Database Syst Rev Date: 2013-04-30
Authors: Holly M Frost; Leisha M Andersen; Katherine E Fleming-Dutra; Chuck Norlin; Christopher A Czaja Journal: Infect Control Hosp Epidemiol Date: 2020-01-10 Impact factor: 3.254
Authors: Milner B Staub; Youssoufou Ouedraogo; Christopher D Evans; Sophie E Katz; Pamela P Talley; Marion A Kainer; George E Nelson Journal: Infect Control Hosp Epidemiol Date: 2020-02 Impact factor: 3.254
Authors: Daniel B Carlsen; Michael J Durkin; Gretchen Gibson; M Marianne Jurasic; Ursula Patel; Linda Poggensee; Margaret A Fitzpatrick; Kelly Echevarria; Jessina McGregor; Charlesnika T Evans; Katie J Suda Journal: Infect Control Hosp Epidemiol Date: 2021-03-02 Impact factor: 3.254
Authors: Edward Stenehjem; Anthony Wallin; Katherine E Fleming-Dutra; Whitney R Buckel; Valoree Stanfield; Kimberly D Brunisholz; Jeff Sorensen; Matthew H Samore; Raj Srivastava; Lauri A Hicks; Adam L Hersh Journal: Clin Infect Dis Date: 2020-04-10 Impact factor: 20.999
Authors: Daniel J Livorsi; Rajeshwari Nair; Andrew Dysangco; Andrea Aylward; Bruce Alexander; Matthew W Smith; Sammantha Kouba; Eli N Perencevich Journal: Open Forum Infect Dis Date: 2021-04-14 Impact factor: 4.423
Authors: Margaret A Olsen; Jacob K Greenberg; Kate Peacock; Katelin B Nickel; Victoria J Fraser; David K Warren Journal: J Antimicrob Chemother Date: 2022-03-31 Impact factor: 5.758
Authors: Anne M Butler; Michael J Durkin; Matthew R Keller; Yinjiao Ma; William G Powderly; Margaret A Olsen Journal: Clin Infect Dis Date: 2022-04-28 Impact factor: 20.999